Developing Treatments for Rare Diseases on a Shoestring

Area of Science:

• Biochemistry
• Genetics
• Medical Research

Background:

• Thousands of rare genetic diseases lack treatments, particularly those affecting children.
• Protein replacement therapy (enzyme replacement or gene therapy) is a potential treatment strategy for genetic disorders caused by protein deficiencies.
• Securing funding for rare disease research is difficult due to small patient populations.

Purpose of the Study:

• To present a novel case study on developing a rare disease treatment.
• To demonstrate an alternative funding model for rare disease research.
• To highlight the use of NIH small business grants for early preclinical development.

Main Methods:

• Utilized NIH small business grants to fund preclinical research.
• Collaborated with academic researchers for early-stage development.
• Focused on a specific rare genetic disease lacking approved treatments.

Main Results:

• Successfully pursued NIH small business grants for research funding.
• Developed a treatment approach for a rare genetic disease without venture capital, angel investment, or foundation support.
• Established a cost-effective method for rare disease treatment development.

Conclusions:

• NIH small business grants can effectively fund early preclinical rare disease research.
• A novel, low-budget approach to rare disease treatment development is feasible.
• This model offers an alternative to traditional funding for rare genetic disorders.